Cargando…
Ligustrazine ameliorates acute kidney injury through downregulation of NOD2-mediated inflammation
Ligustrazine has been used to alleviate clinical acute kidney injury (AKI); however, the underlying molecular mechanisms are poorly understood. In order to further elucidate the molecular mechanism underlying its occurrence, the role of nucleotide-binding oligomerization domain-containing 2 (NOD2) i...
Autores principales: | Jiang, Guosheng, Xin, Rui, Yuan, Wendan, Zhang, Lixia, Meng, Xianghui, Sun, Wangnan, Han, Huirong, Hou, Yun, Wang, Lin, Du, Pengchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015130/ https://www.ncbi.nlm.nih.gov/pubmed/31985025 http://dx.doi.org/10.3892/ijmm.2020.4464 |
Ejemplares similares
-
Pharmacokinetic study on the effect of ligustrazine–tangeretin co‐administration on the pharmacokinetics of ligustrazine and its potential mechanism in rats
por: Liu, Dandan, et al.
Publicado: (2023) -
Ligustrazine monomer against cerebral ischemia/reperfusion injury
por: Gao, Hai-jun, et al.
Publicado: (2015) -
Effect of Ligustrazine on Endometrium Injury of Thin Endometrium Rats
por: Ye, Qing, et al.
Publicado: (2019) -
Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
por: Ma, Shitang, et al.
Publicado: (2022) -
Ligustrazine Inhibits the Migration and Invasion of Renal Cell Carcinoma
por: Zhang, Xufeng, et al.
Publicado: (2023)